sRAGE in septic shock: a potential biomarker of mortality

about

The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis.Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury.

P2860

Q40677347-E7086C93-B6D1-44E1-B945-1A9F49C98044 Q42254916-B3F9FDBB-9298-4EBC-AD58-C150BD18D62B

P2860

sRAGE in septic shock: a potential biomarker of mortality

Item

http://www.wikidata.org/entity/Q39052240

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

sRAGE in septic shock: a potential biomarker of mortality

@en

sRAGE in septic shock: a potential biomarker of mortality.

@nl

type

Item

label

sRAGE in septic shock: a potential biomarker of mortality

@en

sRAGE in septic shock: a potential biomarker of mortality.

@nl

prefLabel

sRAGE in septic shock: a potential biomarker of mortality

@en

sRAGE in septic shock: a potential biomarker of mortality.

@nl

P1476

sRAGE in septic shock: a potential biomarker of mortality

@en

P2093

Fabiano Pinheiro da Silva

http://www.w3.org/2001/XMLSchema#string

Heraldo Possolo de Souza

http://www.w3.org/2001/XMLSchema#string

Marcel Cerqueira César Machado

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis

Understanding RAGE, the receptor for advanced glycation end products.

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

sRAGE induces human monocyte survival and differentiation

RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.

Septic shock is associated with receptor for advanced glycation end products ligation of LPS.

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.

P304

392-396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5935/0103-507X.20140060

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hermes Vieira Barbeiro

Mike Yoshio Hamasaki

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25607269

http://www.w3.org/2001/XMLSchema#string

P921

sepsis

biomarker

P932

4304468

http://www.w3.org/2001/XMLSchema#string

sRAGE in septic shock: a potential biomarker of mortality

about

P2860

P2860

sRAGE in septic shock: a potential biomarker of mortality

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932